Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis. (2021)
Attributed to:
Technologies for the Treatment of Brain Diseases
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cellsig.2021.109931
PubMed Identifier: 33529758
Publication URI: http://europepmc.org/abstract/MED/33529758
Type: Journal Article/Review
Volume: 81
Parent Publication: Cellular signalling
ISSN: 0898-6568